StockData
Elanco Animal Health Inc logo

Elanco Animal Health Inc (ELAN) stock

ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30129% above fair value
$26.70+0.85 (+3.29%)

Close on Nov 18, 2026Market cap $13.34BP/E –Yield –

Elanco Animal Health pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Elanco Animal Health's pe ratio was 401.3× on Jan 30, 2026, against 30.1× a year earlier. Over the last 3 years it ranged from 13.9× to 401.3×, with a median of 106.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 2026401.3×+24.2
2025Dec 31, 2025377.2×+346.9
2024Dec 31, 202430.3×−107.0
2020Apr 30, 2020137.3×+24.0
2019Dec 31, 2019113.3×–

More Elanco Animal Health figures

See a number that looks wrong?